Table 2.
Organism isolated | No | Antimicrobial resistance level of Enterobacteriaceae isolates, n (%)
|
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AML | AMC | SXT | FOX | C | CTX | GM | NOR | TE | FN | IMI | MEM | ||
Escherichia coli | 6 | 6 (100) | 6 (100) | 6 (100) | 3 (50) | 4 (66.7) | 4 (66.7) | 4 (66.7) | 4 (66.7) | 5 (83.3) | 0 (0) | 0 (0) | 0 (0) |
Morganella morganii | 2 | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 0 (0) |
Citrobacter spp. | 1 | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 0 (0) | 0 (0) | 0 (0) |
Salmonella spp. | 1 | 1 (100) | 0 (0) | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (100) | 0 (0) | 0 (0) | 0 (0) |
Enterobacter aerogenes | 1 | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 0 (100) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 0 (0) | 0 (0) | 0 (0) |
Proteus mirabilis | 1 | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Klebsiella oxytoca | 1 | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 0 (00) | 1 (100) | 0 (0) | 0 (0) | 1 (100) | 1 (100) | 0 (0) | 1 (100) |
Klebsiella pneumoniae | 19 | 18 (94.7) | 17 (89.5) | 16 (84.2) | 7 (36.8) | 11 (57.9) | 19 (100) | 17 (89.5) | 3 (15.8) | 14 (73.7) | 9 (47.9) | 2 (10.5) | 3 (15.8) |
Enterobacter cloacae | 1 | 0 (0) | 0 (0) | 1 (100) | 0 (0) | 1 (100) | 1 (100) | 1 (100) | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Total | 33 | 31 (89.1) | 28 (74.5) | 29 (83.6) | 15 (48.1) | 19 (61.8) | 29 (85.5) | 26 (70.9) | 12 (34.5) | 25 (72.7) | 12 (39.6) | 4 (12.2) | 4 (12.2) |
Abbreviations: AML, amoxicillin; AMC, amoxicillin-clavulanic acid; SXT, sulfamethoxazole-trimethoprim; FOX, cefoxitin; C, chloramphenicol; CTX, cefotaxime; GM, gentamicin; NOR, norfloxacin; TE, tetracycline; FN, nitrofurantoin; IMI, imipenem; MEM, meropenem.